Oxytocic Pharmaceuticals Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Oxytocic</strong> <strong>Pharmaceuticals</strong> <strong>Market</strong>: Global Industry Analysis and Forecast 2016 -<br />
2022<br />
are Hipofisina, Evatocin, Litocin, Pitogin, Piton-S and Obcin Octocin. Also, various oxytocic<br />
pharmaceuticals are yet to receive FDA approvals such as Carbetocin, Misoprostol and<br />
Syntocinon.<br />
Depending on geographic region, oxytocic pharmaceuticals market is segmented into seven key<br />
regions: North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North<br />
America is expected to dominate the oxytocic pharmaceuticals market followed by Europe, Asia<br />
Pacific owing to increase in the caesarian procedures, involvement in R&D, government<br />
initiatives, great advancement in field of oxytocic functions, awareness regarding maternal care<br />
and developed healthcare infrastructure. The developing nations in Asia Pacific, Middle East &<br />
Africa hold huge potential for growth in the oxytocic pharmaceuticals market due to prevalence<br />
of delivering child at home that reduces the execution of injections immediately after delivery,<br />
unavailability of oxytocic drugs and healthcare infrastructure facilities.<br />
Key players of oxytocic pharmaceuticals market are App <strong>Pharmaceuticals</strong> LLC, Teva Parenteral<br />
Medicines Inc., Abbott laboratories, JHP <strong>Pharmaceuticals</strong> LLC and Novartis <strong>Pharmaceuticals</strong><br />
Corporation.<br />
The report covers exhaustive analysis on:<br />
<br />
<br />
<strong>Oxytocic</strong> <strong>Pharmaceuticals</strong> <strong>Market</strong> Segments<br />
<strong>Oxytocic</strong> <strong>Pharmaceuticals</strong> <strong>Market</strong> Dynamics<br />
Historical Actual <strong>Market</strong> Size, 2012 - 2014<br />
<strong>Oxytocic</strong> <strong>Pharmaceuticals</strong> <strong>Market</strong> Size & Forecast 2015 to 2022<br />
<br />
<br />
<br />
<strong>Oxytocic</strong> <strong>Pharmaceuticals</strong> <strong>Market</strong> Current Trends/Issues/Challenges<br />
Competition & Companies involved<br />
<strong>Oxytocic</strong> <strong>Pharmaceuticals</strong> <strong>Market</strong> Drivers and Restraints<br />
Regional analysis includes<br />
<br />
<br />
<br />
<br />
<br />
North America<br />
Latin America<br />
Europe<br />
Asia Pacific<br />
Middle East and Africa<br />
Persistence <strong>Market</strong> Research 3